Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 4.05 USD 2.79% Market Closed
Updated: Jun 2, 2024

Design Therapeutics Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Design Therapeutics Inc
Free Cash Flow Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Design Therapeutics Inc
NASDAQ:DSGN
Free Cash Flow
-$58.8m
CAGR 3-Years
-89%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Free Cash Flow
$21.9B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
16%
Gilead Sciences Inc
NASDAQ:GILD
Free Cash Flow
$7.9B
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Free Cash Flow
$7.1B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Free Cash Flow
$3.5B
CAGR 3-Years
5%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Free Cash Flow
$3.9B
CAGR 3-Years
25%
CAGR 5-Years
13%
CAGR 10-Years
27%

See Also

What is Design Therapeutics Inc's Free Cash Flow?
Free Cash Flow
-58.8m USD

Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Free Cash Flow amounts to -58.8m USD.

What is Design Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-89%

Over the last year, the Free Cash Flow growth was -13%. The average annual Free Cash Flow growth rates for Design Therapeutics Inc have been -89% over the past three years .